ENDPOINTS NEWS

Endpoints News Exclusive: Longevity startup targets renegade proteins linked to diabetes and obesity

By Ryan Cross

A new startup called Junevity has raised $10 million to identify those renegade proteins, called transcription factors, that are linked to aging and disease and silence them with long-lasting siRNA therapies.